¼¼°èÀÇ ºô¸®·çºó Ç÷¾× °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Bilirubin Blood Test Global Market Report 2025
»óǰÄÚµå : 1702930
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ºô¸®·çºó Ç÷¾× °Ë»ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 7.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 19¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº Á¶±â Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Áø´Ü ½ÇÇè½Ç È®Àå, ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ½ÅÈï ½ÃÀå ¼ºÀå, °í±Þ ºÐ¼®ÀÇ ÅëÇÕ, ¿¬±¸ ÀÚ±Ý Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ºñħ½ÀÀû °Ë»ç¹ý °³¹ß, µðÁöÅÐ Çコ ¼Ö·ç¼Ç°úÀÇ ÅëÇÕ, °¡Á¤¿ë °Ë»ç ŰƮÀÇ ¹ßÀü, °Ë»ç Á¤È®µµ ¹× ¼Óµµ Çâ»ó, °³ÀÎ ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ý, ½º¸¶Æ® Áø´Ü ±â±â, ÈÞ´ëÇü ±â±â °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

°£ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ºô¸®·çºó Ç÷¾× °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °£ ÁúȯÀº °£ ±â´ÉÀ» È¿°úÀûÀ¸·Î ÀúÇϽÃŰ´Â ´Ù¾çÇÑ º´Å»ý¸®¸¦ Æ÷ÇÔÇϸç, °¨¿°, °úµµÇÑ ¾ËÄÚ¿Ã ¼·Ãë, ´ë»ç ÀÌ»ó µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. °£ Áúȯ ȯÀÚ Áõ°¡´Â ºñ¸¸À² Áõ°¡, °úÀ½, ¹ÙÀÌ·¯½º °¨¿°, °Ç°­¿¡ ÇØ·Î¿î »ýȰ½À°ü ¼±Åðú °ü·ÃÀÌ ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍÀÌ °£ ¼Õ»ó°ú ±â´É Àå¾ÖÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. °£ ÁúȯÀº ü³» ºô¸®·çºó ³óµµ¸¦ Å©°Ô º¯È­½Ã۱⠶§¹®¿¡ ºô¸®·çºó Ç÷¾× °Ë»ç´Â °£ ±â´ÉÀ» Áø´ÜÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â ȯÀÚÀÇ °Ç°­ »óÅ¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇϰí ÀÇ·áÁøÀÌ °£ °ü·Ã ÁúȯÀ» °ü¸®ÇÒ ¶§ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, À¯·´Áúº´¿¹¹æÅëÁ¦¼¾ÅͰ¡ 2024³â 4¿ù¿¡ º¸°íÇÑ ¹Ù¿¡ µû¸£¸é, EU/EEA 30°³±¹ÀÇ 2022³â BÇü °£¿° ¹ÙÀÌ·¯½º(HBV) °¨¿°ÀÚ ¼ö´Â 28,855¸íÀ¸·Î 2021³â 16,187¸íº¸´Ù 78% Áõ°¡ÇßÀ¸¸ç, 2022³â °¨¿°ÀÚ ¼ö´Â Àα¸ 10¸¸ ¸í´ç 8.5¸íÀ̾ú½À´Ï´Ù. ´ç 8.5¸íÀ̾ú½À´Ï´Ù. ÀÌ·¯ÇÑ °£Áúȯ À¯º´·ü Áõ°¡´Â ºô¸®·çºó Ç÷¾× °Ë»ç ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºô¸®·çºó Ç÷¾× °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½ÃÀå ÁøÀÔÀÇ ÆøÀ» ³ÐÈ÷°í Á¦Ç° ¶óÀξ÷À» °­È­Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½ÊÀº ÀÚ¿ø°ú Àü¹® Áö½ÄÀ» °áÇÕÇÏ¿© »óÈ£ ¸ñÇ¥¸¦ ´Þ¼ºÇϱâ À§ÇÑ Á¶Á÷ °£ÀÇ Çù·Â °ü°è¸¦ ÀǹÌÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 12¿ù À̽º¶ó¿¤¿¡ º»»ç¸¦ µÐ ÀÇ·á Áø´Ü¿ë ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ÀÎ Calmark Sweden AB´Â »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ Techno Orbits¿Í ½Å»ý¾Æ ºô¸®·çºó °Ë»ç¿¡ ´ëÇÑ µ¶Á¡ À¯Åë¾÷ü °è¾àÀ» ü°áÇß½À´Ï´Ù. Å×Å©³ë¿ÀºñÃ÷´Â º¸°ÇºÎ¸¦ Æ÷ÇÔÇÑ ±âÁ¸ ³×Æ®¿öÅ©¿Í ÀθÆÀ» Ȱ¿ëÇÏ¿© Ä®¸¶Å© Á¦Ç°ÀÇ À¯Åë°ú ÆÇ¸Å¸¦ °ü¸®ÇÏ°Ô µË´Ï´Ù. À̹ø ÆÄÆ®³Ê½ÊÀº »ç¿ìµð ½ÃÀå¿¡ Ä®¸¶Å©ÀÇ ºô¸®·çºó °Ë»ç µµÀÔÀ» ÃËÁøÇϱâ À§ÇÑ °ÍÀ¸·Î, ±ÔÁ¦ ´ç±¹¿¡ µî·ÏÇÏ´Â µ¥ 3-6°³¿ùÀÌ ¼Ò¿äµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The bilirubin blood test is a diagnostic procedure used to measure bilirubin levels in the blood. This test is important for evaluating liver function and diagnosing conditions such as jaundice and liver disease. It is crucial for assessing bilirubin metabolism and identifying liver health issues.

The main types of bilirubin blood tests includes the total serum bilirubin test, the indirect or unconjugated bilirubin test, and the direct or conjugated bilirubin test. The total serum bilirubin test measures the combined amount of unconjugated (indirect) and conjugated (direct) bilirubin in the blood. This test is essential for assessing overall liver health and diagnosing various liver-related conditions. The test is applicable to adults, pediatrics, and infants, and it is used in hospitals, clinics, and other healthcare settings.

The bilirubin blood test market research report is one of a series of new reports from the business research company that provides bilirubin blood test market statistics, including bilirubin blood test industry global market size, regional shares, competitors with an bilirubin blood test market share, detailed bilirubin blood test market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin blood test industry. This bilirubin blood test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bilirubin blood test market size has grown strongly in recent years. It will grow from $1.37 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the increasing prevalence of liver diseases, growth in neonatal care, technological advancements, rising health awareness, healthcare infrastructure development, regulatory approvals and guidelines, and increased adoption of point-of-care testing.

The bilirubin blood test market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for early diagnosis, expansion of diagnostic laboratories, rising incidence of chronic diseases, emerging markets growth, integration of advanced analytics, increased research funding. Major trends in the forecast period include development of non-invasive testing methods, integration with digital health solutions, advances in home testing kits, enhanced test accuracy and speed, personalized medicine approaches, smart diagnostic devices, development of portable devices.

The increasing prevalence of liver diseases is anticipated to drive the growth of the bilirubin blood test market. Liver diseases encompass a variety of conditions that impair the liver's ability to function effectively, often due to factors such as infections, excessive alcohol consumption, or metabolic disorders. The rise in liver disease cases is linked to escalating obesity rates, high alcohol intake, viral infections, and unhealthy lifestyle choices, all of which contribute to liver damage and dysfunction. Since liver disease can significantly alter bilirubin levels in the body, bilirubin blood tests are essential for diagnosing and monitoring liver function. These tests provide valuable insights into patient health and support healthcare providers in managing liver-related conditions. For example, the European Centre for Disease Prevention and Control reported in April 2024 that there were 28,855 cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, marking a 78% increase from 16,187 cases in 2021. The 2022 cases amounted to a crude rate of 8.5 cases per 100,000 people. This rising incidence of liver diseases is expected to boost the bilirubin blood test market.

Leading companies in the bilirubin blood test market are increasingly forming strategic partnerships to broaden their reach and improve their offerings. A strategic partnership involves a collaborative relationship between organizations that combines resources and expertise to achieve mutual goals. For example, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology firm, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia for its bilirubin test for newborns. Techno Orbits will manage the distribution and sales of Calmark's product, utilizing its established network and connections, including with the Ministry of Health. This partnership aims to facilitate the introduction of Calmark's bilirubin test into the Saudi market, with regulatory registration expected to take between 3 to 6 months.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical technology provider, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition is designed to bolster Mindray's competitive position in the in vitro diagnostic (IVD) sector by leveraging DiaSys's established supply chains and expertise in clinical chemistry. The acquisition is expected to enhance Mindray's capabilities in serving medium- to large-volume customers and improve service delivery. DiaSys Diagnostic Systems GmbH, based in Germany, specializes in diagnostic systems, including bilirubin blood tests for liver diseases.

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Dragerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bilirubin blood test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bilirubin blood test market consists of sales of products such as diagnostic devices for measuring bilirubin levels, including test kits, blood analyzers, and automated testing systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bilirubin Blood Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bilirubin blood test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bilirubin blood test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bilirubin blood test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bilirubin Blood Test Market Characteristics

3. Bilirubin Blood Test Market Trends And Strategies

4. Bilirubin Blood Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bilirubin Blood Test Growth Analysis And Strategic Analysis Framework

6. Bilirubin Blood Test Market Segmentation

7. Bilirubin Blood Test Market Regional And Country Analysis

8. Asia-Pacific Bilirubin Blood Test Market

9. China Bilirubin Blood Test Market

10. India Bilirubin Blood Test Market

11. Japan Bilirubin Blood Test Market

12. Australia Bilirubin Blood Test Market

13. Indonesia Bilirubin Blood Test Market

14. South Korea Bilirubin Blood Test Market

15. Western Europe Bilirubin Blood Test Market

16. UK Bilirubin Blood Test Market

17. Germany Bilirubin Blood Test Market

18. France Bilirubin Blood Test Market

19. Italy Bilirubin Blood Test Market

20. Spain Bilirubin Blood Test Market

21. Eastern Europe Bilirubin Blood Test Market

22. Russia Bilirubin Blood Test Market

23. North America Bilirubin Blood Test Market

24. USA Bilirubin Blood Test Market

25. Canada Bilirubin Blood Test Market

26. South America Bilirubin Blood Test Market

27. Brazil Bilirubin Blood Test Market

28. Middle East Bilirubin Blood Test Market

29. Africa Bilirubin Blood Test Market

30. Bilirubin Blood Test Market Competitive Landscape And Company Profiles

31. Bilirubin Blood Test Market Other Major And Innovative Companies

32. Global Bilirubin Blood Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bilirubin Blood Test Market

34. Recent Developments In The Bilirubin Blood Test Market

35. Bilirubin Blood Test Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â